OncologyTube Professional - Patients Click Here
Oncology VideoBlog
195,401 video views
Loading........
Description: Read the Editorial: http://www.nejm.org/doi/ful...

William Gradishar, MD discusses TDM1
01:19
Read the Editorial: http://www.n... William Gradishar, MD discusses TDM1
by:videoblog | 5575 views
01:05
Read the Editorial: http://www.n... William Gradishar of Northwestern University talks about the NEOSPHERE trial and how that affects the CLEOPATRA Trial
by:videoblog | 4469 views
01:38
Read the Editorial: http://www.n... William Gradishar of Northwestern University discusses his editorial HER2 Therapy — An Abundance of Riches in the New England Journal of Medicine
by:videoblog | 5108 views
00:44
Read Press Release: http://aacrn... Jennifer Crozier, MD - Future studies for Obese and Normal-Weight Patients
by:videoblog | 4379 views
01:17
Read Press Release: http://aacrn... Jennifer Crozier, MD - Future studies for Obese and Normal-Weight Patients
by:videoblog | 4489 views
01:56
Press Release: http://aacrn... Jennifer Crozier, MD - Addition of Trastuzumab May Potentially Equalize Disease-Free Survival Outcomes Among Obese and No...
by:videoblog | 3804 views
01:33
Link to New England Journal of Medicine article: http://www.n... Edith Perez, MD Mayo Clinic discusses the BOLERO-2 Trial - Everolimus in Postmenopausal Hormone-Recepto​r–Positive Advanced Breast Cancer
by:videoblog | 3730 views
01:09
Key Study Results to be Presented at SABCS Pertuzumab * Full results from CLEOPATRA, a randomized Phase III pivotal study that compared the combination of pertuzumab, Herceptin and docetaxel chemotherapy to Herceptin and chemotherapy alone in people with previously untreated HER2-positive me...
by:videoblog | 3520 views
00:47
Jose Baselga, MD - Massachusetts General Hospital Cancer Center what does the CLEOPATRA Pertuzumab Trial mean for the future
by:videoblog | 2443 views
02:02
Genentech to Present Important New Data for HER2-Positive Breast Cancer at 2011 San Antonio Breast Cancer Symposium South San Francisco, Calif. -- November 29, 2011 -- Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced the company will present results from stud...
by:videoblog | 5127 views

About videoblog
Description: A new video blog series with Key Opinion Leaders from a wide range of cancer research disciplines. These video blogs included the latest data from clinical trials and what these trials mean may mean to practicing physicians. Dr. Debu Tripath, M.D. of the USC Norris Comprehensive Cancer Center, Dr. Anne Tsao, M.D. of MD Anderson Cancer Center, Dr. Fonseca, Rafael, M.D. of the Mayo Clinic, and Dr. Ruben Mesa, M.D. of the Mayo Clinic.

Links
Channel Url: